18 Kasım 2026, Çarşamba · 14:20 Piyasalar Açık
borsapanel.com Borsanın nabzı, tek panelde.
Abone Ol

Phreesia’s (PHR) Profit Turnaround Meets A Cash-Strapped Client Base

Phreesia’s (PHR) Profit Turnaround Meets A Cash-Strapped Client Base

Maham Fatima

Sun, September 13, 2026 at 12:53 PM GMT+3 4 min read

On September 2, Phreesia (NYSE:PHR) reported second-quarter fiscal 2027 results for the period ended July 31, showing revenue climbing to $129.5 million and adjusted EBITDA surging to $32.9 million. The healthcare technology company posted its fifth straight quarter of positive net income and its ninth straight quarter of positive operating cash flow, even as management flagged growing unpredictability in one of its core revenue lines. The quarter tells two stories at once: a business getting more efficient, and a client base under real financial pressure.

Phreesia's (PHR) Profit Turnaround Meets A Cash-Strapped Client Base

Profitability Finally Has Momentum

Revenue rose 10% year over year, with growth split between Network Solutions and Payment Solutions. Average healthcare services clients reached 4,744, up 6% from a year earlier, and total revenue per client climbed 4% to $27,289. The bigger story sits below the top line. Adjusted EBITDA jumped $10.8 million year over year to $32.9 million, pushing margin to 25%, while net income hit $1.9 million. Operating cash flow reached $18.3 million and free cash flow $13.8 million, gains of $3.5 million and $4.2 million, respectively.

That cash, combined with existing reserves, let Phreesia retire more than $23 million in debt principal during the quarter. Management also pointed to a May restructuring plan that eliminated 220 positions, about half of them contractor roles, at an estimated total cost of $10 million, of which $2.8 million was recognized this quarter. CEO Chaim Indig credited artificial intelligence with letting the company do things that were "just hard to imagine doing in a non-AI world," particularly in testing and scaling new products.

On the growth side, the newer Provider Connect offering is gaining traction, and a four-month study in the GLP-1 category showed a 4% incremental lift in new-to-brand prescriptions and more than 1,000 new patient starts. Phreesia also expanded a securitization facility so its AccessOne financing arm can offer upfront funding to clients without investment-grade credit.

Cracks Beneath A Strained Client Base

The same call that delivered better margins also delivered a warning. CFO Balaji Gandhi said there is "now more variability in our network solutions revenue forecasting, particularly in the second half of each fiscal year," a direct admission that visibility into that business has gotten murkier. Indig went further, describing healthcare providers as being "under a significant amount of strain" from shifting payer dynamics and broader economic pressure.

Management said it deliberately moderated subscription pricing to help those partners absorb rising costs, a choice that supports client retention but caps near-term pricing power. The numbers show some of that strain already. Total revenue per client fell about 2% sequentially, and total revenue itself dipped roughly 1% from the first quarter, both tied to seasonal declines in payment processing volume once health plan deductibles reset.

Phreesia's cash balance slipped from $76.4 million to $74.6 million during the quarter, and the company still carries $61 million outstanding under its Capital One credit facility. None of this derailed the quarter, but it does mean the debt paydown and margin gains are happening against a backdrop of a client base that is not exactly flush.

Market Signals Stay Mixed

30 hedge funds held Phreesia shares in the most recent quarter, down slightly from 31 the quarter before, which points to modest trimming rather than a rush for the exits. Short interest sits at 5.80% of float, a level suggesting a real but not overwhelming bear camp. The stock trades at a forward P/E of 12.80, as of September 11, a multiple that assumes little of the margin expansion management just delivered. That combination suggests that the market has not fully credited the profitability turnaround yet.

Where The Story Goes From Here

Phreesia enters the back half of fiscal 2027 reaffirming both its $510 million to $520 million revenue outlook and its $125 million to $135 million adjusted EBITDA outlook, with AHSC growth expected in the mid-single digits. The bull case rests on continued EBITDA expansion, debt reduction, and new products like Provider Connect and AccessOne finding traction. The bear case rests on Gandhi's own admission of reduced forecasting visibility, and Indig's description of provider strain, both of which could pressure the very revenue lines guidance depends on.

While we acknowledge the potential of PHR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on thebest short-term AI stock.

READ NEXT: 10 Best Future Stocks to Buy Under $10 and 12 Best Performing Semiconductor Stocks to Invest In.

Disclosure: None. Follow Insider Monkey on Google News.

Kaynak: Yahoo Finance
İlgili Haberler
Global Putin says EU is losing industry, falling behind competition ahead of meeting with Trump, Xi CNBC Finance · 6 saat önce Global "Breaking Bad" dizisinin yıldızı Dean Norris, boşanma sürecindeyken 4,5 hektarlık Kaliforniya'daki mülkünü 3,2 milyon dolara satıyor MarketWatch Top · 1 gün önce Global Nvidia'dan Apple'a kadar ABD'li şirketler artan bir Çin ikilemiyle karşı karşıya CNBC Finance · 1 gün önce Global Berkshire Hathaway raised its stake in Delta in the third quarter. It also trimmed a key bank holding CNBC Finance · 1 gün önce Global JPMorgan Chase says temporary software bug is affecting consumer banking CNBC Finance · 1 gün önce

Yorumlar (0)

Giriş yaparak yorum yazabilirsin.

İlk yorumu sen yaz.